Late-life depression: issues for the general practitioner
| Autor: | Hannelore Tandt, Lieve Lemey, Mirko Petrovic, Axel Van Damme, Tom Declercq |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
RANDOMIZED CONTROLLED-TRIALS SEROTONIN REUPTAKE INHIBITORS Collaborative Care Poison control Disease Review Suicide prevention DISEASE law.invention ELECTROCONVULSIVE-THERAPY 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Medicine and Health Sciences Medicine 030212 general & internal medicine Psychiatry OLDER-ADULTS COLLABORATIVE CARE METAANALYSIS major depressive disorder business.industry PRIMARY-CARE elder care General Medicine Late life depression geriatric mental health medicine.disease COGNITIVE IMPAIRMENT psychosomatic RISK-FACTORS Major depressive disorder geriatric psychiatry business 030217 neurology & neurosurgery Geriatric psychiatry |
| Zdroj: | International Journal of General Medicine INTERNATIONAL JOURNAL OF GENERAL MEDICINE |
| ISSN: | 1178-7074 |
| Popis: | Late-life depression (LLD) is both a prevalent and life-threatening disorder, affecting up to 13.3% of the elderly population. LLD can be difficult to identify because patients mainly consult their general practitioner (GP) for somatic complaints. Moreover, patients may be hesitant to express the problem to their GP. Increased vigilance on the part of the GP can only benefit older people with depression. To recognize the risk of LLD, screening tools are provided in addition to treatment options for LLD. This review aims to provide the GP with guidance in recognizing and treating LLD. It tries to connect mainstream etiologies of LLD (e.g., vascular, inflammation, hypothalamo-pituitary-adrenal axis) with risk factors and current therapies. Therefore, we provide a basis to the GP for decision-making when choosing an appropriate therapy for LLD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|